Treatment of dry age-related macular degeneration

Giuseppe Querques, Philip J Rosenfeld, Edoardo Cavallero, Enrico Borrelli, Federico Corvi, Lea Querques, Francesco M. Bandello, Marco A. Zarbin

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

A number of different approaches are under development for treating nonexudative manifestations of age-related macular degeneration (AMD). Some interventions target specific pathways that are believed to play a role in AMD pathogenesis, e.g. oxidative damage, lipofuscin accumulation, chronic inflammation (including complement activation), extracellular matrix changes (e.g. β-amyloid accumulation), impaired choroidal blood flow, and apoptosis. In principle, these therapies can be combined ('combination therapy'), which may lead to synergistic effects that include better visual outcome, less likelihood for 'escape' (i.e. drug resistance), and less frequent treatment

Original languageEnglish
Pages (from-to)107-115
Number of pages9
JournalOphthalmic Research
Volume52
Issue number3
DOIs
StatePublished - Jan 1 2014

Fingerprint

Macular Degeneration
Lipofuscin
Complement Activation
Drug Resistance
Amyloid
Extracellular Matrix
Apoptosis
Inflammation
Therapeutics

Keywords

  • Age-related macular degeneration
  • Drugs
  • Drusen
  • Geographic atrophy
  • Neurotrophic factors
  • Oxidative damage
  • Pathway
  • Stem cells
  • Treatment
  • Visual cycle

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Querques, G., Rosenfeld, P. J., Cavallero, E., Borrelli, E., Corvi, F., Querques, L., ... Zarbin, M. A. (2014). Treatment of dry age-related macular degeneration. Ophthalmic Research, 52(3), 107-115. https://doi.org/10.1159/000363187

Treatment of dry age-related macular degeneration. / Querques, Giuseppe; Rosenfeld, Philip J; Cavallero, Edoardo; Borrelli, Enrico; Corvi, Federico; Querques, Lea; Bandello, Francesco M.; Zarbin, Marco A.

In: Ophthalmic Research, Vol. 52, No. 3, 01.01.2014, p. 107-115.

Research output: Contribution to journalArticle

Querques, G, Rosenfeld, PJ, Cavallero, E, Borrelli, E, Corvi, F, Querques, L, Bandello, FM & Zarbin, MA 2014, 'Treatment of dry age-related macular degeneration', Ophthalmic Research, vol. 52, no. 3, pp. 107-115. https://doi.org/10.1159/000363187
Querques G, Rosenfeld PJ, Cavallero E, Borrelli E, Corvi F, Querques L et al. Treatment of dry age-related macular degeneration. Ophthalmic Research. 2014 Jan 1;52(3):107-115. https://doi.org/10.1159/000363187
Querques, Giuseppe ; Rosenfeld, Philip J ; Cavallero, Edoardo ; Borrelli, Enrico ; Corvi, Federico ; Querques, Lea ; Bandello, Francesco M. ; Zarbin, Marco A. / Treatment of dry age-related macular degeneration. In: Ophthalmic Research. 2014 ; Vol. 52, No. 3. pp. 107-115.
@article{d0b633581fc5447399b1ae28352438dc,
title = "Treatment of dry age-related macular degeneration",
abstract = "A number of different approaches are under development for treating nonexudative manifestations of age-related macular degeneration (AMD). Some interventions target specific pathways that are believed to play a role in AMD pathogenesis, e.g. oxidative damage, lipofuscin accumulation, chronic inflammation (including complement activation), extracellular matrix changes (e.g. β-amyloid accumulation), impaired choroidal blood flow, and apoptosis. In principle, these therapies can be combined ('combination therapy'), which may lead to synergistic effects that include better visual outcome, less likelihood for 'escape' (i.e. drug resistance), and less frequent treatment",
keywords = "Age-related macular degeneration, Drugs, Drusen, Geographic atrophy, Neurotrophic factors, Oxidative damage, Pathway, Stem cells, Treatment, Visual cycle",
author = "Giuseppe Querques and Rosenfeld, {Philip J} and Edoardo Cavallero and Enrico Borrelli and Federico Corvi and Lea Querques and Bandello, {Francesco M.} and Zarbin, {Marco A.}",
year = "2014",
month = "1",
day = "1",
doi = "10.1159/000363187",
language = "English",
volume = "52",
pages = "107--115",
journal = "Ophthalmic Research",
issn = "0030-3747",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Treatment of dry age-related macular degeneration

AU - Querques, Giuseppe

AU - Rosenfeld, Philip J

AU - Cavallero, Edoardo

AU - Borrelli, Enrico

AU - Corvi, Federico

AU - Querques, Lea

AU - Bandello, Francesco M.

AU - Zarbin, Marco A.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - A number of different approaches are under development for treating nonexudative manifestations of age-related macular degeneration (AMD). Some interventions target specific pathways that are believed to play a role in AMD pathogenesis, e.g. oxidative damage, lipofuscin accumulation, chronic inflammation (including complement activation), extracellular matrix changes (e.g. β-amyloid accumulation), impaired choroidal blood flow, and apoptosis. In principle, these therapies can be combined ('combination therapy'), which may lead to synergistic effects that include better visual outcome, less likelihood for 'escape' (i.e. drug resistance), and less frequent treatment

AB - A number of different approaches are under development for treating nonexudative manifestations of age-related macular degeneration (AMD). Some interventions target specific pathways that are believed to play a role in AMD pathogenesis, e.g. oxidative damage, lipofuscin accumulation, chronic inflammation (including complement activation), extracellular matrix changes (e.g. β-amyloid accumulation), impaired choroidal blood flow, and apoptosis. In principle, these therapies can be combined ('combination therapy'), which may lead to synergistic effects that include better visual outcome, less likelihood for 'escape' (i.e. drug resistance), and less frequent treatment

KW - Age-related macular degeneration

KW - Drugs

KW - Drusen

KW - Geographic atrophy

KW - Neurotrophic factors

KW - Oxidative damage

KW - Pathway

KW - Stem cells

KW - Treatment

KW - Visual cycle

UR - http://www.scopus.com/inward/record.url?scp=84910643156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84910643156&partnerID=8YFLogxK

U2 - 10.1159/000363187

DO - 10.1159/000363187

M3 - Article

VL - 52

SP - 107

EP - 115

JO - Ophthalmic Research

JF - Ophthalmic Research

SN - 0030-3747

IS - 3

ER -